STOCK TITAN

Sintx Technologies, Inc. - $SINT STOCK NEWS

Welcome to our dedicated page for Sintx Technologies news (Ticker: $SINT), a resource for investors and traders seeking the latest updates and insights on Sintx Technologies stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sintx Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sintx Technologies's position in the market.

Rhea-AI Summary
SINTX Technologies, Inc. (SINT) has been granted its sixth United States patent in the last year, all related to the antipathogenic properties of silicon nitride. The significance of the patents lies in their innovative approaches towards utilizing silicon nitride in a wide range of antipathogenic solutions, covering applications in agriculture, dentistry, medical implants, durable medical equipment, and personal protective equipment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
none
-
Rhea-AI Summary
SINTX Technologies, Inc. has entered a Long-Term Agreement to supply jet engine components made of its silicon nitride, expanding its capabilities beyond biomedical implants. The agreement has no minimum requirements and is projected to generate annual revenues of less than $0.25 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.5%
Tags
none
-
Rhea-AI Summary
SINTX Technologies has been awarded a Phase II grant of $1,972,826 by the NIH to develop a 3D printed composite spinal implant. The grant represents a critical milestone in expanding the antibacterial and osseointegrative properties of silicon nitride into composite structures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
Rhea-AI Summary
3DCERAM Sinto, Inc. and SINTX Technologies, Inc. announced a collaboration to develop novel resins and processes for additive manufacturing of ceramic products. The collaboration aims to produce high-value resins, 3D print ceramic components, and subject them to advanced thermal processing, primarily for the biomedical and investment casting industries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.81%
Tags
none
-
Rhea-AI Summary
SINTX Technologies, Inc. closes public offering, raising approximately $12.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.93%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-45.87%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.82%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
57.16%
Tags
none
Sintx Technologies, Inc.

Nasdaq:SINT

SINT Rankings

SINT Stock Data

11.20M
22.68M
8.82%
1.88%
2.39%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SALT LAKE CITY

About SINT

amedica is the only manufacturer of medical grade silicon nitride, an innovative biomaterial technology ideal for use in spinal fusion and across a variety of medical applications. our silicon nitride features a unique nanosurface texture that promotes bone growth and addresses clinical needs by providing excellent imaging capabilities and demonstrating antibacterial characteristics. our interbody fusion devices and pedicle screw systems are designed to benefit both the patient and the surgeon. with the only fda registered and iso 1345 certified silicon nitride medical device manufacturing facility in the world and a strong sales and distribution organization, we are committed to providing innovative healthcare solutions that improve patient quality of life.